Regulatory Digest 2026-03-09
Regulatory updates (higher clinical relevance)
Daily Cannabis News Digest: Top Updates March 8, 2026
This daily cannabis news digest provides top updates from the cannabis industry and research pipeline. Stay informed on medical cannabis news and policy developments. Our digest covers key highlights from March 8, 2026.
Regulatory Digest: Marijuana Rescheduling and Clinical Research
Marijuana rescheduling clinical research is a pivotal topic in 2026 regulatory updates. This shift could enable expanded clinical trials and evidence-based cannabis therapeutics. Understanding these changes is essential for clinicians and researchers…
Endocannabinoid System Research: Cannabis PTSD Meta-Analysis
This cannabis PTSD meta-analysis examines trauma-focused treatment outcomes in patients with co-occurring substance use disorders. Findings show trauma-focused therapies remain effective regardless of cannabis use. Clinicians should consider these…
Digital Mental Health Intervention: Cannabis Clinical Research Insights
This page reviews digital mental health intervention cannabis research insights focusing on a randomized controlled trial of a student-codeveloped app. The study evaluates the effectiveness of app-based support for mental health and substance use…
Cannabinoids in Pediatric Care: Clinical Evidence Review
This review focuses on cannabinoid safety pediatric use, summarizing evidence from 276 studies including interventional and observational research. The clinical evidence supports cautious use of cannabinoids in pediatric medicine for select conditions.…
Cannabinoid Clinical Trials: Cannabis for Student Mental Health
The Minder mobile mental health app was tested in a randomized controlled trial to assess its impact on student mental health and substance use. This digital intervention offers scalable support during the critical transition to higher education. Results…
Endocannabinoid System Research: Cannabis in Mental Health RCTs
This study evaluates a digital mental health intervention designed for university students during a critical transition period. The Minder mobile app, tested in a randomized controlled trial, shows promise in improving mental health and substance use…
Endocannabinoid System Research: Cannabinoids in Pediatrics
Cannabinoids pediatric research is expanding with numerous studies examining safety and efficacy in children. This living systematic review highlights 276 studies across various pediatric conditions. Clinicians should consider this evolving evidence base…
Regulatory Digest: DEA Enforcement & Controlled Substances March 2026
This regulatory digest covers DEA enforcement controlled substances updates relevant to cannabis and synthetic cannabinoid importation. The March 2026 notices highlight scheduling changes and import restrictions. Clinicians should stay informed about…
